LivaNova PLC (LIVN) is in Healthcare, Medical Devices, based in United Kingdom, listed on NasdaqGS. Market cap 4.18B USD. 52-week range 48.82 to 85.76 USD. Trailing P/E 22.5. Data as of 2026-10-09.
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an ...